Beximco Pharmaceuticals Limited (BXP)
Exchange: London Exchange • Country: Bangladesh • Currency: GBX • Type: Common Stock • ISIN: -s
Beximco Pharmaceuticals Limited, listed on the London Stock Exchange as BXP, is a leading manufacturer in Bangladesh, producing generic pharmaceutical formulations and active pharmaceutical ingredients.
The company offers a wide range of products, including those for allergic disorders, cardiovascular health, respiratory issues, and more. They also provide contract manufacturing services to other businesses, ensuring quality products reach the market.
With a diverse product line in various dosage forms like tablets, syrups, inhalers, and injectables, Beximco Pharmaceuticals serves both local and international markets. Their products are known for meeting global standards of quality and efficacy.
Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited continues to expand its reach globally. To learn more about their operations, visit their website at https://www.beximcopharma.com.
Drawdown (Underwater) Chart
BXP Stock Overview
| Market Cap in USD | 2m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| GiC SubIndustry | Biotechnology |
| TER | 0.00% |
| IPO / Inception |
BXP Stock Ratings
| Growth 5y | 0.72 |
| Fundamental | 75.4 |
| Dividend | 7.95 |
| Rel. Performance vs Sector | -1.31 |
| Analysts | - |
| Fair Price Momentum | 33.79 GBX |
| Fair Price DCF | 224.81 GBX |
BXP Dividends
| Yield 12m | 8.70% |
| Yield on Cost 5y | 8.92% |
| Dividends CAGR 5y | 14.62% |
| Payout Consistency | 62.3% |
BXP Growth Ratios
| Growth 12m | -18.91% |
| Growth Correlation 12m | 9% |
| Growth Correlation 3m | -24% |
| CAGR 5y | 0.58% |
| Sharpe Ratio 12m | -0.72 |
| Alpha vs SP500 12m | -29.82 |
| Beta vs SP500 5y weekly | 0.31 |
| ValueRay RSI | 39.49 |
| Volatility GJR Garch 1y | 33.73% |
| Price / SMA 50 | -5.56% |
| Price / SMA 200 | -2.17% |
| Current Volume | 5.5k |
| Average Volume 20d | 97.2k |
External Links for BXP Stock
As of April 26, 2024, the stock is trading at GBX 36.50 with a total of 5,473 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -7.59%, over three months by +4.29% and over the past year by -5.39%.
According to ValueRays Forecast Model, BXP Beximco Pharmaceuticals Limited will be worth about 36.5 in April 2025. The stock is currently trading at 36.50. This means that the stock has a potential downside of -0.03%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 148 | 305 |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.5 | -0.03 |